Navigation Links
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications
Date:6/22/2012

SAN JOSE, Calif., June 23, 2012 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the BD FACSJazz™ Cell Sorting System, a next-generation flow cytometer that simplifies cellular isolation and analysis for researchers requiring high sample integrity. Occupying 20" x 20" (51 cm x 51 cm) of benchtop space, the new sorter features high sensitivity to identify and isolate target cells for up to eight parameters.

"As a leader in cell analysis, BD's goal is to make advanced cell isolation and sorting accessible to all researchers, with all levels of experience," said Alberto Mas, Worldwide President, BD Biosciences. "The BD FACSJazz Cell Sorting System offers, for the first time, an extremely powerful tool for the identification and isolation of single or multiple cells even from complex or extremely rare cell populations right from the benchtop. With application across a number of applications, we believe that this product will complement the recent and very rapid advances in genomic studies where sample integrity is critical for next-generation sequencing and sequence detection."

The new BD FACSJazz Cell Sorting System will have broad utility for next-generation genomic studies. The system is capable of identifying, characterizing and isolating single or multiple cells and depositing them in 96 and 384 well plates with precision, accuracy and rapidity.

The BD FACSJazz Cell Sorting System incorporates customer input from a 2011 global early access program. As a result, refinements were made to enhance usability and ease of use. In addition, a violet laser and pulse processing were added to the offering to enhance live dead cell discrimination and cell cycle analysis. 

The system has many innovative features that simplify
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Billians HealthDATA Expands Market Coverage to Include Physician Group Practices
2. CareFusion Expands Infusion Pump Interoperability
3. AMRI Further Expands Discovery Capabilities in India
4. DATATRAK Expands CDISC Registered Solutions Provider Standards
5. The UCB-Harvard Research Alliance Expands and Moves Forward
6. CarePoint Partners Expands Coverage in Southeast
7. BHR Pharma Expands SyNAPSe® Trial into Thailand, China and Russia
8. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
9. Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
10. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
11. USANA Health Sciences Expands Award-Winning Research and Development Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... N.J. and INDIANAPOLIS, March 29, 2011 Oral ... the updated clinical practice guidelines as a Class ... coronary intervention (PCI) after experiencing heart-related chest pain ... myocardial infarction (NSTEMI).  NSTEMI is a type of ...
... MicroCHIPS, Inc., a developer of innovative drug delivery devices ... and Trademark Office has granted U.S. Patent No. 7,892,221, ... patent in conjunction with U.S. Patent No. 7,070,590 provides ... medical devices used for implantable drug delivery systems. ...
Cached Medicine Technology:Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 2Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 3Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 4Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 5Effient® Added to Updated ACCF/AHA Clinical Guidelines for ACS-PCI Patients with Unstable Angina and Non-ST Segment Myocardial Infarction 6MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems 2
(Date:4/23/2014)... frozen stool from healthy, unrelated donors was safe ... diarrhea caused by Clostridium difficile , according ... Clinical Infectious Diseases and available online. Known ... effective whether given via a colonoscope or a ... make this promising treatment more readily available to ...
(Date:4/23/2014)... looking to give exercise enthusiasts the extra nudge they ... that a cyber buddy can help. , The study, ... , is the first to indicate that although a ... a software-generated partner also can be effective. , "We ... still motivate people to give greater effort while exercising ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... (April 23, 2014) The American Gastroenterological Association ... 2014 AGA Research Scholars. The AGA Research Scholar ... to develop independent and productive research careers in ... Awards fund an additional year allowing for three ... to supporting junior faculty who are paving the ...
(Date:4/23/2014)... A team of scientists led by a researcher from ... the National University of Singapore has identified the cancer ... opens up the possibility of developing new drugs for ... cancers. , The research group, led by Dr Chan ... for the first time that a cancer-specific variant of ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... has the second most populous Jewish community in America, ... Florida for economic opportunities, for the climate, to join ... growing Jewish population of Broward County is now declining ... University of Miami professor Dr. Ira M. Sheskin, from ...
... March 10 A recent CBS 60 Minutes ... a red wine molecule believed to largely be ... French have far more people living beyond 100 ... from heart disease than other people living in ...
... , , TUESDAY, March 10 (HealthDay News) -- The chances of ... that sells alcohol to go, according to a study by ... and around off-premise alcohol outlets were shot as the victims ... were easier targets or they were shot as the victims ...
... Omega Protein Corporation (NYSE: OME ), the ... fish meal products, today reported net income of $12.6 ... December 31, 2008, compared with net income of $12.1 ... 31, 2007.(Logo: http://www.newscom.com/cgi-bin/prnh/20030516/OMEGALOGO )For the year ended ...
... LAKEWOOD, Colo., March 10 Mesa Laboratories, Inc. ... consumables for healthcare and manufacturing quality control applications, today announced ... of Chief Executive Officer (CEO), replacing Luke R. Schmieder, who ... Mr. Schmieder is retiring from Mesa and resigning his ...
... of packaging traceability posed by regulated medical wasteCLEVELAND, ... a leader in label, packaging , promotion ... placard identification reusable labeling solution to meet stringent ... containers for biomedical waste. Subject to governmental regulations, ...
Cached Medicine News:Health News:UM study reveals demographic trend of the Jewish population in Broward County 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 3Health News:Shootings Linked to Alcohol-to-Go Outlets, Study Finds 2Health News:Omega Protein Reports 2008 Results 2Health News:Omega Protein Reports 2008 Results 3Health News:Omega Protein Reports 2008 Results 4Health News:Omega Protein Reports 2008 Results 5Health News:Mesa Labs Announces the Appointment of New CEO 2Health News:Mesa Labs Announces the Appointment of New CEO 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 2Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 3Health News:Kennedy Group Applies Its Packaging Expertise to Reusable Labeling in Handling Biomedical Waste Disposal 4
... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
... of German Craftsmanship have produced ... the world. Ocutek® now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
Medicine Products: